CD206+IL-4Rα+ Macrophages Are Drivers of Adverse Cardiac Remodeling in Ischemic Cardiomyopathy
Myocardial infarctions (MI), or more commonly known as heart attacks, have prolonged health implications that affect millions worldwide. Chronic heart failure (HF) is very common after a heart attack, with about 20-30% of patients developing it within a year. Heart failure after MI is characterized by distinct structural, cellular, and molecular changes that differentiate...
View Details
Collagen Hybridizing Peptides (CHPs) Elucidate Ursolic Acid's Efficacy in Collagen Homeostasis
Tissue fibrosis, pathologically characterized by the excessive and dysfunctional deposition of extracellular matrix (ECM) components, notably collagen, remains a significant challenge in chronic disease management. Fibrosis accounts for nearly half of all mortality in the United States. Effective therapeutic strategies must engage a dual mechanism, simultaneously arresting neo-collagenesis and actively degrading existing, pathological collagen...
View Details
CHPs Contribute to Abdominal Aortic Anurrysm (AAA) Research)
Abdominal Aortic Aneurysm (AAA) is a life-threatening condition characterized by the extensive remodeling and breakdown of the extracellular matrix (ECM). Understanding the factors governing aortic instability - particularly the micro/nanoscale changes - is paramount for improving AAA management. A new publication, "Nano-mechanical Mapping of Human and Porcine Abdominal Aortic Aneurysm" uses advanced imaging techniques...
View Details
CHP Staining: Unlocking a New Therapeutic Strategy for Fibrosis
Fibrosis, the pathological accumulation of collagen and other ECM components, is a major health concern implicated in an estimated ⅓ of all natural deaths. While current anti-fibrotic drugs aim to slow progression, advanced fibrosis is often left untreated, leaving transplantation the only remaining option in many cases. A new therapeutic approach is focusing on...
View Details
Damaged collagen detected by collagen hybridizing peptide as efficient diagnosis marker for early hepatic fibrosis
Liver fibrosis, a significant pathological consequence of chronic liver disease and damage, is characterized by the excessive accumulation of extracellular matrix (ECM) proteins. This build up of non-functional scar tissue progressively replaces healthy tissue in the liver, leading to conditions such as cirrhosis, liver failure, and heightened risk of liver cancer. With a high...
View Details
Collagen Hybridizing Peptides (CHPs): Unraveling the role of Denatured Collagen in Neuroblastoma.
The complex interplay between the tumor microenvironment (TME) and cancer progression is a critical area of research, particularly in aggressive childhood cancers like neuroblastoma (NB). A recent study, “Unraveling the Role of Denatured Collagen in Neuroblastoma via Collagen Hybridizing Peptides,” published in July 2023, has shed light on the impact of thermal ablation on...
View Details
Resolving fibrosis by stimulating HSC-dependent extracellular matrix degradation
Fibrosis is not just characterized by extracellular matrix (ECM) component deposition, but it’s better described as an imbalance between the production and breakdown of the ECM. Current treatments for fibrosis largely focus on stopping ECM production, but there is a significant, untapped potential in promoting its breakdown. Matrix metalloproteinases (MMPs) are enzymes that degrade...
View Details
Pinpointing Fibrosis: How Collagen Hybridizing Peptides Illustrate Muscle Wasting in Pancreatic Cancer
Muscle wasting in cancer is estimated to contribute to approximately 30% of cancer-related deaths, with a deterioration of respiratory muscles implicated as a major cause of mortality. One of the most lethal cancers, Pancreatic ductal adenocarcinoma (PDAC), also has the highest prevalence and earliest onset of cachexia of all cancers. While researchers knew that...
View Details



